| Literature DB >> 31492474 |
Julianne E Rollenhagen1, Colleen M Woods2, Aisling O'Dowd1, Steven T Poole1, Jing-Hui Tian3, Mimi Guebre-Xabier3, Larry Ellingsworth3, Michael G Prouty4, Greg Glenn3, Stephen J Savarino5.
Abstract
dscCfaE is a recombinant form of the CFA/I tip adhesin CfaE, expressed by a large proportion of enterotoxigenic E. coli (ETEC). It is highly immunogenic by the intranasal route in mice and Aotus nancymaae, protective against challenge with CFA/I+ ETEC in an A. nancymaae challenge model, and antibodies to dscCfaE passively protect against CFA/I+ ETEC challenge in human volunteers. Here, we show that transcutaneous immunization (TCI) with dscCfaE in mice resulted in strong anti-CfaE IgG serum responses, with a clear dose-response effect. Co-administration with heat-labile enterotoxin (LT) resulted in enhanced immune responses over those elicited by dscCfaE alone and strong anti-LT antibody responses. The highest dose of dscCfaE administered transcutaneously with LT elicited strong HAI titers, a surrogate for the neutralization of intestinal adhesion. Fecal anti-adhesin IgG and IgA antibody responses were also induced. These findings support the feasibility of TCI for the application of an adhesin-toxin based ETEC vaccine. Published by Elsevier Ltd.Entities:
Keywords: Adhesin; CFA/I; CfaE; ETEC; TCI; Transcutaneous
Mesh:
Substances:
Year: 2019 PMID: 31492474 DOI: 10.1016/j.vaccine.2019.08.057
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641